陕西博硕律师事务所 关于金花企业（集团）股份有限公司 2025 年第一次临时股东大会的法律意见书 致：金花企业（集团）股份有限公司 根据《中华人民共和国证券法》（以下简称《证券法》）、《中华人民共和 国公司法》（以下简称《公司法》）和中国证券监督管理委员会《上市公司股东 会规则》（以下简称《股东会规则》）等法律、行政法规、规范性文件及《金花 企业（集团）股份有限公司章程》（以下简称《公司章程》）的规定，陕西博硕 律师事务所（以下简称本所）接受金花企业（集团）股份有限公司（以下简称公 司）的委托，指派律师出席公司 2025 年第一次临时股东大会（以下简称本次股 东大会）。 本所律师仅对本次股东大会的召集程序、召开程序、出席会议人员资格、召 集人资格、表决程序、表决结果发表法律意见，并不对本次股东大会审议的议案 所涉及的数字及内容发表意见。本所律师同意将本法律意见书随本次股东大会其 他信息披露资料一并公告。本法律意见书仅供见证公司本次股东大会相关事项的 合法性之目的使用，不得用作任何其他目的。 本所及经办律师依据《证券法》、《律师事务所从事证券法律业务管理办法》 和《律师事务所证券法律业务执业规则（试行）》等规定 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 证券代码：600080 证券简称：金花股份 公告编号：2025-039 金花企业（集团）股份有限公司 2025年第一次临时股东大会决议公告 (一)股东大会召开的时间：2025 年 9 月 8 日 (二)股东大会召开的地点：陕西省西安市高新三路财富中心三期南座 40 层会议 室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 137 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 97,507,985 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股份 | 26.1226 | | 总数的比例（%） | | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次会议由公司董事会召集，采取现场和网络投票相结合的方式召开，由董 事长邢雅江先生主持本次股东大会，现场会议采取记名投票表决的 ...

Market Overview - The Chinese traditional medicine sector experienced a decline of 0.82% on September 4, with ST Xiangxue leading the drop [1] - The Shanghai Composite Index closed at 3765.88, down 1.25%, while the Shenzhen Component Index closed at 12118.7, down 2.83% [1] Stock Performance - Notable gainers in the traditional medicine sector included: - Wanbangde (002082) with a closing price of 9.98, up 3.42% and a trading volume of 487,100 shares, totaling 482 million yuan [1] - Shengtang Pharmaceutical (833266) closed at 11.20, up 2.38% with a trading volume of 39,300 shares, totaling 44.12 million yuan [1] - Significant decliners included: - ST Qingyin (300147) with a closing price of 10.18, down 6.86% and a trading volume of 288,600 shares, totaling 301 million yuan [2] - Weikang Pharmaceutical (300878) closed at 21.42, down 6.83% with a trading volume of 54,300 shares, totaling 118 million yuan [2] Capital Flow - The traditional medicine sector saw a net outflow of 819 million yuan from institutional investors, while retail investors contributed a net inflow of 925 million yuan [2] - The capital flow for specific stocks showed: - Wanbangde (002082) had a net inflow of 30.53 million yuan from institutional investors, while retail investors had a net outflow of 19.38 million yuan [3] - Jianmin Group (600976) experienced a net inflow of 26.19 million yuan from institutional investors, with retail investors seeing a net outflow of 23.73 million yuan [3]

Core Viewpoint - Jinhua Co., Ltd. reported a decline in revenue and net profit for the first half of 2025, indicating financial challenges despite a slight recovery in the second quarter [1] Financial Performance - Total revenue for the first half of 2025 was 241 million yuan, a year-on-year decrease of 1.9% - Net profit attributable to shareholders was 6.195 million yuan, down 34.53% year-on-year - In Q2 2025, total revenue was 134 million yuan, an increase of 2.91% year-on-year, while net profit rose significantly by 134.34% to 4.9797 million yuan [1] Key Financial Ratios - Gross margin stood at 76.59%, a slight decrease of 0.1% year-on-year - Net profit margin was 2.56%, down 33.39% year-on-year - Total selling, administrative, and financial expenses amounted to 157 million yuan, accounting for 65.17% of revenue, a decrease of 2.6% year-on-year [1] Cash Flow and Assets - Operating cash flow per share was -0.22 yuan, a decrease of 250.37% year-on-year - Cash and cash equivalents decreased by 48.74% due to increased investment in new facilities and fixed assets [2] - Trade financial assets decreased by 64.02% due to the disposal of such assets [3] Liabilities and Expenses - Total liabilities showed significant changes, with contract liabilities decreasing by 67.84% and other current liabilities down by 93.16% [4] - R&D expenses increased by 83.2%, indicating a focus on innovation despite financial pressures [4] Investment Returns - The company's return on invested capital (ROIC) was 4.45% last year, with a historical median of 1.88% over the past decade, indicating weak investment returns [4] - The worst year for ROIC was 2023, with a value of -2.63%, highlighting ongoing challenges in generating returns [4] Business Model Insights - The company's performance is primarily driven by marketing efforts, necessitating a deeper analysis of the underlying factors [5] - Cash flow and accounts receivable metrics raise concerns, with cash flow to current liabilities at 57.97% and accounts receivable exceeding profits by 154.69% [5]

Group 1 - Gujia Home achieved a net profit of 1.02 billion yuan in the first half of 2025, a year-on-year increase of 13.89% [1] - Gujia Home's revenue for the first half of 2025 was 9.80 billion yuan, up 10.02% year-on-year [1] - Phoenix Holdings reported a net profit of 11.04 million yuan, successfully turning a profit [1] - Phoenix Holdings' revenue increased by 200.78% year-on-year to 291 million yuan [1] - Zheshang Securities recorded a net profit of 1.15 billion yuan, a year-on-year growth of 46.49% [1] - Zheshang Securities' revenue decreased by 23.66% to 6.11 billion yuan [1] Group 2 - Tianjin Port's net profit was 503 million yuan, a year-on-year decrease of 18.33% [3] - Tianjin Port's revenue for the first half of 2025 was 6.18 billion yuan, an increase of 4.33% year-on-year [3] - Xuantai Pharmaceutical reported a net profit of 45.59 million yuan, down 15.82% year-on-year [5] - Xuantai Pharmaceutical's revenue was 220 million yuan, a slight increase of 0.74% year-on-year [5] Group 3 - Yilida achieved a net profit of 40.03 million yuan, a year-on-year increase of 18.32% [7] - Yilida's revenue for the first half of 2025 was 758 million yuan, up 12.56% year-on-year [7] - Zhongji United reported a net profit of 262 million yuan, a significant year-on-year increase of 86.61% [9] - Zhongji United's revenue was 818 million yuan, a year-on-year growth of 43.52% [9] Group 4 - China Shipbuilding Special Gas reported a net profit of 178 million yuan, a slight decrease of 0.55% year-on-year [10] - China Shipbuilding Special Gas' revenue was 1.04 billion yuan, an increase of 12.60% year-on-year [10] - Xinyuan Intelligent Manufacturing achieved a net profit of 9.79 million yuan, a year-on-year increase of 284.45% [11] - Xinyuan Intelligent Manufacturing's revenue was 329 million yuan, up 388.33% year-on-year [11] Group 5 - Jiudian Pharmaceutical reported a net profit of 291 million yuan, a year-on-year increase of 2.57% [13] - Jiudian Pharmaceutical's revenue was 1.51 billion yuan, a year-on-year growth of 10.67% [13] - Boya Biological reported a net profit of 225 million yuan, down 28.68% year-on-year [15] - Boya Biological's revenue was 1.01 billion yuan, an increase of 12.51% year-on-year [15] Group 6 - True Love Home achieved a net profit of 197 million yuan, a year-on-year increase of 484.48% [17] - True Love Home's revenue was 390 million yuan, up 21.82% year-on-year [17] - Dongfang Electronics reported a net profit of 302 million yuan, a year-on-year increase of 19.65% [19] - Dongfang Electronics' revenue was 3.16 billion yuan, a year-on-year growth of 12.18% [19] Group 7 - Watte Holdings achieved a net profit of 18.41 million yuan, a year-on-year increase of 23.94% [21] - Watte Holdings' revenue was 906 million yuan, up 12.29% year-on-year [21] - Tianqin Equipment reported a net profit of 16.36 million yuan, a year-on-year increase of 2.78% [22] - Tianqin Equipment's revenue was 111 million yuan, a year-on-year growth of 18.42% [22] Group 8 - Yingfeng Environment achieved a net profit of 382 million yuan, a year-on-year increase of 0.43% [24] - Yingfeng Environment's revenue was 6.46 billion yuan, up 3.69% year-on-year [24] - Kexin Machinery reported a net profit of 52.20 million yuan, a year-on-year decrease of 46.18% [26] - Kexin Machinery's revenue was 592 million yuan, down 17.26% year-on-year [26] Group 9 - Tengda Construction reported a net profit of 108 million yuan, a year-on-year decrease of 0.69% [27] - Tengda Construction's revenue was 1.61 billion yuan, down 5.20% year-on-year [27] - Canaan Technology achieved a net profit of 7.35 million yuan, a year-on-year decrease of 38.46% [29] - Canaan Technology's revenue was 560 million yuan, up 1.29% year-on-year [29] Group 10 - Metro Design reported a net profit of 221 million yuan, a year-on-year increase of 6.58% [30] - Metro Design's revenue was 1.32 billion yuan, up 5.31% year-on-year [30] - China Shipbuilding Special Gas plans to use up to 2.9 billion yuan of idle funds for cash management [31] - The company intends to invest in safe, liquid, principal-protected products [31] Group 11 - Jiuchuang Biotechnology received a medical device registration certificate for its lupus anticoagulant detection kit [32] - The product is intended for in vitro qualitative detection of lupus anticoagulant in human plasma [32] - Xinowei's subsidiary received approval for clinical trials of its innovative drug [33] - The drug is a humanized monoclonal antibody intended for treating multiple cancers [33] Group 12 - Dongcheng Pharmaceutical's subsidiary received FDA approval for clinical trials of its targeted radiopharmaceutical [34] - The drug is intended for treating advanced prostate cancer [34] - Shandong Road and Bridge received approval to issue bonds up to 4 billion yuan [35] - The company specializes in road and bridge engineering construction [35] Group 13 - Diou Home plans to invest 500 million yuan to establish a subsidiary focused on generative AI [36] - The investment aims to transform the company into a full-stack industrial intelligent service provider [36] - Dayilong achieved a net profit of 90.87 million yuan, a year-on-year increase of 217.89% [37] - Dayilong's revenue was 957 million yuan, up 57.35% year-on-year [37] Group 14 - Chaohongji reported a net profit of 331 million yuan, a year-on-year increase of 44.34% [38] - Chaohongji's revenue was 4.10 billion yuan, up 19.54% year-on-year [38] - Taiji Group reported a net profit of 139 million yuan, a year-on-year decrease of 71.94% [39] - Taiji Group's revenue was 5.66 billion yuan, down 27.63% year-on-year [39] Group 15 - Suneng Co. reported a net profit of 93.19 million yuan, a year-on-year decrease of 90.13% [41] - Suneng Co.'s revenue was 5.57 billion yuan, down 17.15% year-on-year [41] - Three Gorges Water Conservancy reported a net profit of 47.93 million yuan, a year-on-year decrease of 79.07% [42] - Three Gorges Water Conservancy's revenue was 4.90 billion yuan, down 6.10% year-on-year [42] Group 16 - Furida reported a net profit of 108 million yuan, a year-on-year decrease of 15.16% [44] - Furida's revenue was 1.79 billion yuan, down 7.05% year-on-year [44] - Chenzhou Electric International achieved a net profit of 25.92 million yuan, a year-on-year increase of 29.55% [46] - Chenzhou Electric International's revenue was 1.96 billion yuan, up 1.26% year-on-year [46] Group 17 - Farlantek achieved a net profit of 122 million yuan, a year-on-year increase of 41.05% [47] - Farlantek's revenue was 1.18 billion yuan, up 46.63% year-on-year [47] - Huitai Medical reported a net profit of 425 million yuan, a year-on-year increase of 24.11% [48] - Huitai Medical's revenue was 1.21 billion yuan, up 21.26% year-on-year [48] Group 18 - Dameng Data's director is under investigation for suspected violations [49] - The company's daily operations remain normal [49] - Maiwei Co. reported a net profit of 394 million yuan, a year-on-year decrease of 14.59% [50] - Maiwei Co.'s revenue was 4.21 billion yuan, down 13.48% year-on-year [50] Group 19 - Waiservice Holdings achieved a net profit of 384 million yuan, a year-on-year increase of 5.51% [52] - Waiservice Holdings' revenue was 12.25 billion yuan, up 16.15% year-on-year [52] - Huakang Co. reported a net profit of 134 million yuan, a year-on-year decrease of 3.38% [53] - Huakang Co.'s revenue was 1.87 billion yuan, up 37.32% year-on-year [53] Group 20 - Bluelight Optical achieved a net profit of 103 million yuan, a year-on-year increase of 110.27% [54] - Bluelight Optical's revenue was 577 million yuan, up 52.54% year-on-year [54] - Shunwang Technology reported a net profit of 162 million yuan, a year-on-year increase of 69.22% [55] - Shunwang Technology's revenue was 1.01 billion yuan, up 25.09% year-on-year [55] Group 21 - Anbiping reported a net loss of 12.50 million yuan in the first half of 2025 [56] - Anbiping's revenue was 159 million yuan, down 30.11% year-on-year [56] - Jinhua Co. reported a net profit of 6.20 million yuan, a year-on-year decrease of 34.53% [57] - Jinhua Co.'s revenue was 241 million yuan, down 1.90% year-on-year [57] Group 22 - Xiehe Electronics achieved a net profit of 28.96 million yuan, a year-on-year decrease of 8.31% [59] - Xiehe Electronics' revenue was 451 million yuan, up 12.13% year-on-year [59] - Huguang Co. reported a net profit of 276 million yuan, a year-on-year increase of 8.40% [60] - Huguang Co.'s revenue was 3.63 billion yuan, up 6.20% year-on-year [60]

Core Viewpoint - Jinhua Co., Ltd. reported a decline in revenue and net profit for the first half of 2025, attributed to increased R&D expenses and a lack of investment gains from the previous year [1] Financial Performance - For the first half of 2025, Jinhua Co. achieved operating revenue of 241 million yuan, a year-on-year decrease of 1.9% [1] - The net profit attributable to shareholders was 6.195 million yuan, down 34.53% year-on-year [1] - R&D expenses saw a significant increase of 83.2% during the reporting period [1] - The net cash flow from operating activities was -80.93 million yuan [1] Stock Performance - As of August 21, 2025, Jinhua Co. shares closed at 8.08 yuan, up 0.62% from the previous trading day [1] - The trading volume for the day was 65,858 hands, with a transaction amount of 53 million yuan and a fluctuation of 1.74% [1] - On August 21, 2025, the net outflow of main funds was 2.3434 million yuan, accounting for 0.08% of the circulating market value [1] - Over the past five days, the net inflow of main funds was 6.3297 million yuan, representing 0.21% of the circulating market value [1] Product Line - Jinhua Co. is engaged in the research, production, and sales of pharmaceuticals, with a product line that includes chemical drugs, traditional Chinese medicine, raw materials, and health products [1] - The company's leading product, Jintian Ge capsules, is a national Class I new drug and has become a first-line medication in orthopedic clinical practice [1] - The company also offers a range of pediatric medications, including children's cough syrup [1]

Group 1 - The company reported a revenue of 241,292,963.66 yuan for the first half of 2025, representing a year-on-year decrease of 1.90% [2] - The net profit attributable to shareholders of the listed company was 6,195,011.43 yuan, showing a year-on-year decline of 34.53% [2]

（文章来源：证券日报） 证券日报网讯 8月21日晚间，金花股份发布公告称，公司第十届监事会第十三次会议审议通过了《公司 2025年半年度报告及摘要》等多项议案。 ...

每经AI快讯，金花股份（SH 600080，收盘价：8.08元）8月21日晚间发布公告称，公司第十届第二十二 次董事会会议于2025年8月20日在公司会议室召开。会议审议了《公司2025年半年度报告》等文件。 2024年1至12月份，金花股份的营业收入构成为：医药工业占比99.89%，医药商业占比0.14%，酒店业 占比0.03%，内部抵销占比-0.06%。 截至发稿，金花股份市值为30亿元。 每经头条（nbdtoutiao）——核心产品净值仅剩7毛钱，昔日"公募一哥"任泽松怎么了？牛市踏空真相曝 光 （记者 王晓波） ...

金花股份（SH 600080，收盘价：8.08元）8月21日晚间发布半年度业绩报告称，2025年上半年营业收入 约2.41亿元，同比减少1.9%；归属于上市公司股东的净利润约620万元，同比减少34.53%；基本每股收 益0.0176元，同比减少32.57%。 （文章来源：每日经济新闻） ...